Multisystem inflammatory syndrome after SARS-CoV-2 vaccination (MIS-V), to interpret with caution
Karthikeyan P. Iyengar, Arvind Nune, Pranav Ish, Rajesh Botchu, Madapura K Shashidhara, Vijay Kumar Jain
Abstract
The introduction of safe and effective vaccines to prevent SARS-CoV-2 infection has been one of the key strategies in the global control of COVID-19 pandemic as they help in preventing SARS-CoV-2 infections (both symptomatic or asymptomatic), severe illness, COVID-19-related hospitalisation and mortality.1 Side effects from COVID-19 vaccinations are usually minor and include local pain at injection site or general musculoskeletal features. There are multiple reports of adverse events following vaccination (AEFI), however, as causation is often not established, such AEFI must always be interpreted with caution. Multisystem inflammatory syndrome in children (MIS-C) and adults (MIS-A) after COVID-19 infection has been described in the UK, Europe and the USA. This may lead to a poor prognosis if not diagnosed and treated early.2 3 A similar …